Unpacking the Federal Drug Price Reduction Struggle
How Political Rhetoric and Behind-the-Scenes Deal-Making Obscure Who Really Pays – or How Much
In Their Own Words
The following excerpt is from an op-ed that first appeared in STAT News on January 11th, 2024.
My daughter Katie was born with severe disabilities. She went on to develop profound autism, attention deficit disorder, and obsessive-compulsive disorder. The hardest part for her is knowing that she’s different but not understanding how or why. My career as a health care manager and now a researcher has been derailed and fragmented because I have a profoundly disabled daughter who has undergone so many treatments and required special schools.
Still, she has grown up. At 21, she now has health insurance and stable income through Medicaid and Social Security. She is fortunate to live in 24/7/365 state-supervised residential housing. The abrupt transition from school-age support to limited adult services is aptly termed “the cliff.” I often wonder: What will happen to my daughter when I am too old to advocate for her?
The good news for both of us is that as of late September, the National Institutes of Health recognizes people with disabilities as a minority population that experiences health disparities. Other recognized health disparities groups include racial and ethnic minorities, people with low socioeconomic status, rural underserved communities, and sexual and gender minorities. This new designation will eventually bring new research-based, systemwide interventions, leading to improved health outcomes.
Twenty-seven percent of the U.S. population lives with a disability, and nearly half of those say they are in bad health. Those with disabilities face a greater incidence of physical and mental ailments, including obesity, diabetes, cardiovascular disease, addiction, and mental illness, as well as increased rates of morbidity and mortality. They struggle to access high-quality medical care and suffer from stigma, biases, and ableism. People with disabilities are also subject to social disadvantage and marginalization.
Read the entire op-ed here.

How Political Rhetoric and Behind-the-Scenes Deal-Making Obscure Who Really Pays – or How Much
Even With Lower Prices, Medicare, Medicaid, and Other Insurers Tighten Coverage for Drugs Like Mounjaro and Zepbound Using Prior Authorization and Other Tools
Guidelines Matter, but Lasting Health Requires Investment in Better Food, More Activity, and More Targeted Tools From Medicaid and SNAP
A Wharton–Netter Center Collaboration Uses Experiential Learning to Build a Health Care Workforce Pipeline
Cheaper Housing Could be a Way to Lower Hospitalizations Among Medicaid Patients with Heart Failure
An LDI Expert Connects Nurse Wellbeing and Staffing to Patient Safety Outcomes